Last edition
News about "Amphastar Pharmaceuticals "
Amphastar Secures FDA Approval for Generic Iron Sucrose Injection
The US FDA has approved Amphastar's Abbreviated New Drug Application (ANDA) for iron sucrose injection, an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.
Amphastar Pharmaceuticals | 12/08/2025 | By Dineshwori
Amphastar to Expand US Manufacturing Footprint, Quadruple Production Capacity
Amphastar Pharmaceuticals aims to quadruple its production capacity at its headquarters in Rancho Cucamonga, California over the next three to five years.
Amphastar Pharmaceuticals | 16/07/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy